156 related articles for article (PubMed ID: 34081054)
1. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
[TBL] [Abstract][Full Text] [Related]
2. Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
Can C; Gündoğan C; Kömek H
Clin Nucl Med; 2021 Apr; 46(4):e233-e235. PubMed ID: 33031232
[TBL] [Abstract][Full Text] [Related]
3. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Civan C; Isik EG; Simsek DH
Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
[TBL] [Abstract][Full Text] [Related]
4. Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.
Verma P; Malhotra G; Meshram V; Chandak A; Sonavane S; Lila AR; Bandgar TR; Asopa RV
Clin Nucl Med; 2021 Aug; 46(8):e406-e409. PubMed ID: 33883490
[TBL] [Abstract][Full Text] [Related]
5. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Has Simsek D; Civan C; Erdem S; Sanli Y
Clin Nucl Med; 2021 Jul; 46(7):579-581. PubMed ID: 33782292
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
7. Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT.
Pernthaler B; Nazerani Hooshmand T; Igrec J; Kvaternik H; Aigner RM
Clin Nucl Med; 2021 Apr; 46(4):e231-e232. PubMed ID: 33086280
[TBL] [Abstract][Full Text] [Related]
8. PET/CT With 68Ga-PSMA and 18F-FDG in Metastatic Adenoid Cystic Carcinoma: Report of 2 Cases.
Isgoren S; Hekimsoy T; Koroglu E; Demir H
Clin Nucl Med; 2022 May; 47(5):e423-e424. PubMed ID: 35234196
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
Kesim S; Oksuzoglu K
Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach.
Miceli A; Riondato M; D'Amico F; Donegani MI; Piol N; Mora M; Spina B; Morbelli S; Bauckneht M
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577898
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Brain Metastasis of Triple Negative Breast Cancer With High Uptake in 68Ga-PSMA-11 PET/CT.
Arslan E; Ergül N; Karagöz Y; Gedik AA; Çermik TF
Clin Nucl Med; 2021 Feb; 46(2):e106-e108. PubMed ID: 33065618
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-PSMA-HBED-CC PET/CT Findings in a Patient of Polyostotic Fibrous Dysplasia.
Malhotra G; Aute PP; Awasare S; Asopa RV
Clin Nucl Med; 2021 Jul; 46(7):e349-e352. PubMed ID: 33417342
[TBL] [Abstract][Full Text] [Related]
13. Solitary Femoral Nodal Metastasis Identified With 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Hilliar L; Yip JWL; Wong VCK; Le K; Mansberg R
Clin Nucl Med; 2021 Feb; 46(2):173-174. PubMed ID: 33315675
[TBL] [Abstract][Full Text] [Related]
14. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT.
Usmani S; Rasheed R; Al Kandari F; Ahmed N
Clin Nucl Med; 2021 Aug; 46(8):661-663. PubMed ID: 33512948
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Jochumsen MR; Gormsen LC; Nielsen GL
Clin Nucl Med; 2018 Feb; 43(2):117-119. PubMed ID: 29261620
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study.
Shamim SA; Kumar N; Arora G; Kumar D; Pathak A; Thakkar A; Sikka K; Singh CA; Kakkar A; Bhalla AS
Clin Nucl Med; 2023 Nov; 48(11):e509-e515. PubMed ID: 37812520
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-Prostate-Specific Membrane Antigen-Avid Malignant Pleural Effusion in a Patient With Metastatic Adenoid Cystic Carcinoma and Concordance With 18F-FDG PET/CT.
Uijen MJM; Weijers JAM; Driessen CML; van Herpen CML; Nagarajah J
Clin Nucl Med; 2022 Feb; 47(2):140-141. PubMed ID: 35006109
[TBL] [Abstract][Full Text] [Related]
19. Incidental 68Ga-Prostate-Specific Membrane Antigen Uptake in Compression Fracture of a Vertebral Body.
Kesim S; Oksuzoglu K; Ozguven S; Erdil TY
Clin Nucl Med; 2021 Jul; 46(7):e371-e372. PubMed ID: 33443948
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
